Angeline Bartholomeusz

Author

Victorian Infectious Diseases Reference Laboratory

Also Known As

A BARTHOLOMEUSZ, A Bartholomeusz, A. Bartholomeusz, A. I. Bartholomeusz, ANGELINE BARTHOLOMEUSZ, Angeline Bartholomeusz, Angeline I. Bartholomeusz, Bartholomeusz, A, Bartholomeusz, Angeline Ingrid

Publications

Citations

H-Index

Concepts

All Affiliations

Victorian Infectious Diseases Reference Laboratory Monash University The Alfred Hospital The Royal Melbourne Hospital St Vincent's Hospital Melbourne

About

Angeline Bartholomeusz is an author at Victorian Infectious Diseases Reference Laboratory specializing in medicine, hepatitis, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	21	2.3K
2	Natural Sciences	3	3	139
3	Public Health	2	2	117
4	Health Sciences	1	1	537
5	Biochemistry	1	1	12

Angeline Bartholomeusz

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase Peter Angus, Rhys Vaughan, Shelly Xiong, Gastroenterology Novel MutationMolecular VirologyPathogenesisImmunologyDipivoxil Therapy	2003	567
Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine Daniel J. Tenney, Steven M. LeVine, R.E. Rose, Antimicrobial Agents and Chemotherapy VaccinationClinical EmergenceHealth SciencesViral HepatitisAntiviral Drug Development	2004	537
Selection of Hepatitis B Virus Polymerase Mutations in HIV-Coinfected Patients Treated with Tenofovir Julie Sheldon, Nuria Camino, Berta Rodés, Antiviral Therapy	2005	288
Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation George Lau, Ming‐Liang He, Angeline Bartholomeusz, Hepatology	2002	193
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy Gail Matthews, Angeline Bartholomeusz, Stephen Locarnini, AIDS	2006	181
Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation Thein Thein Aye, Angeline Bartholomeusz, Tim Shaw, Journal of Hepatology TransplantationHepatologyViral HepatitisHepatitis BHepatitis	1997	146
Comparisons of the Hbv and HIV Polymerase, and Antiviral Resistance Mutations Angeline Bartholomeusz, Benjamin G. Tehan, David K. Chalmers Antiviral Therapy Viral ReplicationImmunologyMolecular BiologyChronic Hepatitis BAntiviral Drug	2004	120
Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu Geoffrey W. McCaughan, Jenean Spencer, David J. Koorey, Liver Transplantation and Surgery TransplantationHepatologyViral HepatitisLamivudine TherapyImmunology	1999	114
The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss Robert A. de Man, Angeline Bartholomeusz, Hubert G.M. Niesters, Journal of Hepatology Transplant RejectionSequential OccurrenceTransplantationHepatologyViral Hepatitis	1998	101
The L80I Substitution in the Reverse Transcriptase Domain of the Hepatitis B Virus Polymerase Is Associated with Lamivudine Resistance and Enhanced Viral Replication In Vitro Nadia Warner, Stephen Locarnini, Michael J. Kuiper, Antimicrobial Agents and Chemotherapy Viral ReplicationReverse Transcriptase DomainHepatitis BMolecular BiologyPathology	2007	101

Page 1